Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Alicia Olarte"'
Autor:
Javier Martin-Broto, Alicia Olarte-García, Ricardo Fernandéz-Rodríguez, Marta Ribeiro Ferreira, Irene Carrasco-García, Fernando Galvez-Montosa, Inmaculada Rincon-Perez, Javier Peinado-Serrano, Ignacio Azinovic, Laura Guzman-Gomez, Lurdes Salgado, Alberto Sevillano, Justo Ortega, Cristina Alvarez, Antonio Gutierrez, David S. Moura, Nadia Hindi
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background and objectives: Dimensional response is an unmet need in second lines of advanced soft tissue sarcomas (STS). Indeed, the three approved drugs, pazopanib, trabectedin, and eribulin, achieved an overall response rate (ORR) of less than 10%.
Externí odkaz:
https://doaj.org/article/1475ef79f82c4873859ed0806a878ff3
Autor:
Germán Valtueña, Marta Santisteban, L. Arbea, Luis Naval-Gías, Matías Jurado, Mikel San-Julian, Juan Alcalde, Mauricio Cambeiro, Alicia Olarte, Luis Isaac Ramos, Rafael Martínez-Monge
Publikováno v:
Brachytherapy. 14:565-570
Purpose To determine whether the time to loading (TTL) affects locoregional control. Methods and Materials Locoregional control status was determined in 301 patients enrolled in several perioperative high-dose-rate brachytherapy (PHDRB) prospective s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ff1f6f6db9313ff99227919e557b126
https://doi.org/10.1016/j.brachy.2015.01.006
https://doi.org/10.1016/j.brachy.2015.01.006
Autor:
Luis Isaac Ramos, Juan Alcalde, Matías Jurado, Alicia Olarte, Mauricio Cambeiro, Rafael Martínez-Monge, Germán Valtueña, Luis Naval-Gías, Mikel San-Julian
Publikováno v:
Brachytherapy. 13:591-596
Purpose To determine whether perioperative high-dose-rate brachytherapy (PHDRB) implants with larger high-dose regions produce increased locoregional control. Methods and Materials Patients ( n = 166) enrolled in several PHDRB prospective studies con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe77f62d9c684447831b6e04d19e31aa
https://doi.org/10.1016/j.brachy.2014.05.015
https://doi.org/10.1016/j.brachy.2014.05.015
Autor:
E. Villafranca, Matías Jurado, Luis Isaac Ramos, Mauricio Cambeiro, Alicia Olarte, Rafael Martínez-Monge, Natividad Bascón, Maria E. Rodriguez-Ruiz
Publikováno v:
Brachytherapy. 13:219-224
Purpose To report the disease-free Grade ≥3 complication-free survival of a Phase II protocol of reirradiation with high-dose-rate (HDR) interstitial brachytherapy (ITB) in previously irradiated gynecologic cancer. Methods and Materials Fifteen pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89cbccb48e04090a6e74cb323376552e
https://doi.org/10.1016/j.brachy.2014.01.008
https://doi.org/10.1016/j.brachy.2014.01.008
Autor:
Alicia Olarte, Lucia Ceniceros, Christian D. Rolfo, Jairo Legaspi, M. Moreno, Eduardo Castanon, Germán Valtueña, Ignacio Gil-Bazo, José Javier Aristu
Publikováno v:
Clinical and translational oncology
Lung cancer is the most frequent neoplasm in humans. Surgery is considered the best therapeutic approach for stage I non-small lung cell cancer (NSCLC). However, a remarkable amount of patients are considered as inoperable. Stereotactic body radiothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4a1d8687c238c9d9dd36016eef1c8a5
https://hdl.handle.net/10067/1322300151162165141
https://hdl.handle.net/10067/1322300151162165141
Autor:
Marta Moreno-Jiménez, Javier Aristu, Jose Luis Perez-Gracia, Alicia Olarte, Ignacio Gil-Bazo, Rafael Martínez-Monge, Leire Arbea, Mauricio Cambeiro, Ignacio Pascual
Publikováno v:
Brachytherapy. 15(2)
Purpose To compare rectal toxicity, urinary toxicity, and nadir+2 PSA relapse-free survival (bRFS) in two consecutive Phase II protocols of high-dose-rate (HDR) brachytherapy used at the authors institution from 2001 to 2012. Methods and Materials Pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f483616c62042c44a41e1828d0e79ea
https://pubmed.ncbi.nlm.nih.gov/26832677
https://pubmed.ncbi.nlm.nih.gov/26832677
Autor:
Mauricio Cambeiro, Alicia Olarte, Marta Aguilar Moreno, Germán Valtueña, Javier Aristu, Natalia Rodríguez-Spiteri Sagredo, B. Olartecoechea, Rafael Martínez-Monge, Jesus Javier Sola Gallego, Leire Arbea, Fernando Martínez-Regueira, Luis Pina Insausti
Publikováno v:
Brachytherapy. 13:S81
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f17f27df8dd110ab1538ce55c2667f30
https://doi.org/10.1016/j.brachy.2014.02.343
https://doi.org/10.1016/j.brachy.2014.02.343
Autor:
Ana Patiño-García, Víctor Collado, Inés López, Maria Pilar Andueza, Ignacio Gil-Bazo, Maria A Rodriguez, Jose Luis Perez Gracia, E. Arevalo, Maria Antonia Fotuño, Eduardo Castanon, Alicia Olarte
Publikováno v:
ResearcherID
e19112 Background: TS is the main biological target of the antifolate Pem. Some TS Pol may confer a short survival and a poor response to antifolate-treated colo-rectal cancer pts. Whether TS genotype has an independent prognostic/predictive impact o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b25082268de6af0b7e1deb665c8a8fc0
https://doi.org/10.1200/jco.2013.31.15_suppl.e19112
https://doi.org/10.1200/jco.2013.31.15_suppl.e19112
Autor:
Itziar Gardeazabal, Pablo Dominguez, María Isabel Velayos Martínez, Ignacio Gil-Bazo, Lucia Ceniceros, Marta Santisteban, Leyre Zubiri Oteiza, Jaime Espinós, Diego Salas, Oscar Fernández-Hidalgo, Patricia Martin, Pablo Sala, Alicia Olarte, Jairo Legaspi, Eduardo Castanon Alvarez, Javier Aristu, Iosune Baraibar, Germán Valtueña, J.P. Fusco, José Manuel Aramendía
Publikováno v:
ResearcherID
e13057 Background: Recurrent high grade malignant gliomas (MGs) have a short survival. Initial standard therapy is based on surgery followed by concurrent radiotherapy with Temozolomide (TMZ) and s...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6c21af92b8a09fa3316c0b68d58a8f0
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000358036902505&KeyUID=WOS:000358036902505
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000358036902505&KeyUID=WOS:000358036902505
Autor:
Germán Valtueña, Leire Arbea-Moreno, E. Arevalo, Marta Moreno-Jiménez, Ignacio Gil-Bazo, Javier Aristu, Maria E. Rodriguez-Ruiz, Alicia Olarte García
Publikováno v:
Radiation Oncology (London, England)
Background Stereotactic ablative body radiation (SABR) is a novel and sophisticated radiation modality that involves the irradiation of extracranial tumors through precise and very high doses in patients with oligometastatic lung disease and primary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b00a9a2c4029565457f08fe69d1b779